文献速递造血干细胞移植与细胞治疗

缺乏短链脂肪酸受体GPR109A的同种反应性T细胞诱导较轻的移植物抗宿主病

Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease.
PubMed 文献 · Blood · 2022-01-01

该研究在小鼠同种异体造血细胞移植(allo-HCT)和移植物抗宿主病(GVHD)模型中探索短链脂肪酸受体GPR109A的作用。移植Gpr109a-/- T细胞较野生型T细胞显著降低GVHD发病率和死亡率,减少靶器官病理及同种反应性T细胞增殖和归巢。Gpr109a-/- T细胞在allo激活后凋亡增加、线粒体氧化磷酸化受损,N-乙酰半胱氨酸(NAC)可逆转。

要点

  • 供者T细胞GPR109A缺失减轻GVHD发病和死亡
  • Gpr109a-/- T细胞allo激活后凋亡增加、氧化磷酸化受损
  • NAC抗氧化治疗可逆转Gpr109a-/- T细胞的线粒体缺陷

核心结论

  • 同种反应性T细胞表达GPR109A对其代谢稳态和扩增至关重要,是allo-HCT后诱导GVHD的必要特征。

研究设计与样本

  • 在小鼠同种异体造血细胞移植(allo-HCT)和GVHD模型中,比较Gpr109a-/-与野生型T细胞移植后的GVHD表现。

主要发现

  • 移植Gpr109a-/- T细胞较野生型T细胞显著降低GVHD发病率和死亡率。
  • 接受Gpr109a-/- T细胞的小鼠GVHD相关靶器官病理减少,同种反应性T细胞增殖和向靶组织归巢下降。
  • Gpr109a-/- T细胞在稳态下无免疫缺陷,但allo激活后凋亡增加且线粒体氧化磷酸化受损。
  • N-乙酰半胱氨酸(NAC)抗氧化治疗可逆轉Gpr109a-/- T细胞的线粒体氧化磷酸化受损。

临床怎么用

  • 供者T细胞GPR109A表达可能成为减轻GVHD的潜在干预靶点。
  • NAC抗氧化治疗可能逆转GPR109A缺失T细胞的代谢缺陷,但需进一步临床验证。

局限性

  • 研究为小鼠模型,结论外推至人类需谨慎。
  • 未报告GPR109A在人类T细胞中的表达和功能数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The intestinal microbiota is essential for the fermentation of dietary fiber into short-chain fatty acids (SCFA) such as butyrate, acetate, and propionate. SCFAs can bind to the G-protein-coupled receptors GPR43 and GPR109A (HCAR2), with varying affinities to promote cellular effects in metabolism or changes in immune function. We explored the role of GPR109A as the main receptor for butyrate in mouse models of allogeneic hematopoietic cell transplantation (allo-HCT) and graft-versus-host disease (GVHD). Deletion of GPR109A in allo-HCT recipients did not affect GVHD, but transplantation of T cells from GPR109A knockout (KO) (Gpr109a-/-) mice into allo-HCT recipient mice significantly reduced GVHD morbidity and mortality compared with recipients of wild-type (WT) T cells. Recipients of Gpr109a-/- T cells exhibited less GVHD-associated target organ pathology and decreased proliferation and homing of alloreactive T cells to target tissues. Although Gpr109a-/- T cells did not exhibit immune deficits at a steady state, following allo-activation, Gpr109a-/- T cells underwent increased apoptosis and were impaired mitochondrial oxidative phosphorylation, which was reversible through antioxidant treatment with N-acetylcysteine (NAC). In conclusion, we found that GPR109A expression by allo-activated T cells is essential for metabolic homeostasis and expansion, which are necessary features to induce GVHD after allo-HCT.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Docampo MD, da Silva MB, Lazrak A, et al. Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease. Blood. 2022. PMID: 34653248. doi:10.1182/blood.2021010719

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。